Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

Exercise induces a temporary decrease in DNA methylation. by Albert Nguyen (2580886)

K8 knockdown leads to a decrease in migration. by Nileema Khapare (159958)

Sphingomyelin enrichment decreased membrane fluidity in 3T3-F442A adipocytes. by Nehman Makdissy (739088)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

“…Conclusions: Low dose atropine eyedrops were effective in decreasing myopia progression in 65% of this population studied for 2 years. …”

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

“…Mitochondrial cytochrome c signals in control cells (control mito) were almost identical after 8 h, 16 h and 24 h and are therefore shown as means ± standard deviations from all times. …”

Downregulation of CIP2A leads to decrease of phosphorylated Akt in lung cancer cells. by Liang Ma (37793)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Subjects:

TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

PK profile of: (a) The developed NanoFDC and (b) Combination of the free candidate drugs. by Anjuman Arora (750291)

Subjects:

<i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

Sharp decrease in infection incidence between 2007 and 2008. by Denis Valle (197557)

Tom clone number and area decrease during pupariation. by Jeremy Brown (3311742)

Single wavelength dose response kinetics for MS2. 254 = LP 254 nm and 285 = UV LED 285 nm. by Daniel Ma (12698752)

Subjects: